Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib with Cetuximab and IMRT for Locally Advanced Head and Neck Cancer
NCT03024489Phase 2Active, not recruiting
- Sponsor
- Mahidol University
- Start
- Jul 2017
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Mahidol University. Started Jul 2017; status: active, not recruiting.
02
Drugs
palbociclib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03024489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024489.